Abstract:
Research attempts are still being driven by the need to find successful therapies for lung and colon cancer, with an emphasis on utilizing natural substances. Of them, apigenin has attracted notice due to its intriguing bioactive characteristics. This work investigates the creation of novel bioactive compounds using apigenin and its metabolites for the treatment of lung and colon cancer. It does this by using computational and structure-activity relationship (SAR) methodologies. We are able to learn more about the pharmacological profiles and molecular interactions of these drugs using SAR analysis and computational modeling. The results pave the path for additional laboratory testing and practical application by highlighting the probable use of apigenin and its derivatives as worthwhile candidates for curative option in lung and colon cancer.
